ProjectA Randomized, Open label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving…
Basic data
Title:
A Randomized, Open label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once weekly versus Twice weekly Carfilzomib Dosing
Duration:
01/08/2015 to 31/07/2018
Abstract / short description:
A Randomized, Open label, Phase 3 Study in Subjects with Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination with Dexamethasone, Comparing Once weekly versus Twice weekly Carfilzomib Dosing
Keywords:
clinical trial
klinische Studie
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Department of Diagnostic and Interventional Radiology
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Mannheim, Baden-Württemberg, Germany